2019
DOI: 10.5935/0004-2749.20190086
|View full text |Cite
|
Sign up to set email alerts
|

Bilateral pseudomonas endophalmitis after immediately sequential bilateral cataract surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Nevertheless, no cases of bilateral endophthalmitis have been reported in which the proper aseptic technique had been followed, and the theoretical risk for simultaneous bilateral postoperative endophthalmitis with proper aseptic technique is estimated to be less than 1 in 100 000 000. 5,11 No case of bilateral TASS has ever been reported.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, no cases of bilateral endophthalmitis have been reported in which the proper aseptic technique had been followed, and the theoretical risk for simultaneous bilateral postoperative endophthalmitis with proper aseptic technique is estimated to be less than 1 in 100 000 000. 5,11 No case of bilateral TASS has ever been reported.…”
Section: Discussionmentioning
confidence: 99%
“…When using published protocols and treating both eyes as separate surgical events, the likelihood of bilateral simultaneous endophthalmitis is exceedingly low. Reported cases have been the consequence of major breachs in sterile technique or otherwise substandard surgical techniques [ 13 ]. Interestingly, US surgeons have less concern regarding the importance of endophthalmitis than their European counterparts ( p =0.006), yet European surgeons are still greater than 2.5 times more likely to perform ISBCS.…”
Section: Discussionmentioning
confidence: 99%
“…Numerous reports in both the US and abroad have demonstrated the safety and e cacy of ISBCS [6,7]. Safety concerns include risk for bilateral endophthalmitis, bilateral toxic anterior segment syndrome (TASS), and inability to re ne lens implant calculations for the fellow eye [8,9], but these concerns have largely not been supported by ndings in the literature when proper protocols are used [10][11][12][13]. Patient bene ts from ISBCS include more rapid binocular vision recovery, a decreased number of office visits, and a decreased amount of travel time, whereas the healthcare system benefits from decreased costs [14][15][16].…”
Section: Introductionmentioning
confidence: 99%